Skip to main content
Log in

Cetuximab + radiotherapy good value for head and neck cancer

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Brown B, Robinson P, Launois R, Griebsch I.Cost-effectiveness of cetuximab (Erbitux Rm) in combination with radiotherapy versus radiotherapy alone in the treatment of locally advanced head and neck cancer in France. Value in Health 9: A289, No. 6, Nov-Dec 2006

  2. Brosa M, Robinson P, Brown B.Cost-effectiveness of cetuximab in combination with radiotherapy versus radiotherapy alone in the treatment of locally advanced head and neck cancer in Spain. Value in Health 9: A281, No. 6, Nov-Dec 2006

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cetuximab + radiotherapy good value for head and neck cancer. Pharmacoecon. Outcomes News 522, 4 (2007). https://doi.org/10.2165/00151234-200705220-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705220-00009

Keywords

Navigation